focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,781.00
Bid: 1,780.50
Ask: 1,781.50
Change: 25.00 (1.42%)
Spread: 1.00 (0.056%)
Open: 1,743.50
High: 1,781.50
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Weaker pound unable to keep FTSE in green

Fri, 19th Aug 2022 12:06

(Alliance News) - London's FTSE 100 outperformed peers but was unable to stave off selling pressure in a tough session for European stocks on Friday, despite sitting just above positive territory for much of the late-morning's trade.

London's large-cap benchmark got a lift from a weaker pound, a tailwind for its overseas earners. Weakness in travel stocks and the retail sector following a poor UK confidence reading hit the index, however.

The FTSE 100 was down 8.43 points, or 0.1%, at 7,533.42. The FTSE 250 index was down 116.24 points, or 0.6%, at 20,020.41. The AIM All-Share index was down 3.52 points, or 0.4%, at 921.04.

The Cboe UK 100 index was down 0.1% at 752.79. The Cboe 250 was down 0.7% at 17,301.67. The Cboe Small Companies was down 0.1% at 14,337.79.

In Paris, the CAC 40 was down 0.8%, while the DAX 40 in Frankfurt was down 0.7%.

Stocks in New York were called lower on Friday. The Dow Jones Industrial Average was called down 0.6%, the S&P 500 was called 0.8% lower and the Nasdaq Composite down 0.9%.

Sterling quoted at USD1.1852 midday Friday, roughly a one-month low, plummeting from USD1.2000 at the London equities close on Thursday.

"The consumer backdrop feels increasingly gloomy and that's bad news because consumer spending is such an important contributor to the UK economy," AJ Bell analyst Danni Hewson commented.

"That's reflected in weakness in the pound, which is actually good news for a globally-orientated FTSE 100 as it flatters the relative value of overseas earnings."

UK retail sales defied expectations and grew on a monthly basis in July, figures on Friday showed, though they slightly missed a year-on-year forecast. On a monthly basis, sales increased 0.3% in July from June, outperforming expectations of a 0.2% decline. They had fallen 0.2% on a monthly basis in June.

UK retail sales volumes fell 3.4% on a yearly basis in July, a sharper than the FXStreet-cited market consensus of a 3.3% slide, however. In June, they had slumped 6.1% year-on-year.

Ahead of the data, a long-running UK consumer confidence tracker hit a record low.

GfK's consumer confidence index fell three points in August to minus 44, its lowest figure since records began in 1974.

Shares in London-listed retailers fell on Friday, in the wake of the poor consumer confidence reading and tricky outlook for the sector.

DIY retailer Kingfisher lost 2.3%, while high street outfits Next and JD Sports lost 1.3% and 1.4% respectively.

On AIM, Joules tumbled 36%. Scorching hot weather has hit sales of winter clothing, including "rainwear, knitwear, and wellies". Trading over the five weeks to August 14 has "softened materially," it cautioned.

Margins have taken a hit and Joules now expects a "significant loss" in its first half. It expects an improved second half, as it reaps the rewards of self-help work.

The euro stood at USD1.0057 midday Friday in London, down from USD1.0132 late Thursday. Roughly a month ago, the dollar hit parity with the single currency. Against the yen, the dollar was trading at JPY136.74, up sharply from JPY135.10.

"The US dollar and Treasury yields were supported by Fed policymakers' comments. St Louis Fed President [James] Bullard said he is leaning towards another 75 basis point increase in interest rates at next month's policy meeting while he also attempted to douse speculation of rate cuts next year," analysts at Lloyds Bank commented.

Markets are also looking towards next week's Jackson Hole Economic Symposium in Wyoming, US.

Analysts at Swiss bank UBS expect the tone from monetary policymakers to be hawkish at next week's meet.

"We anticipate a rather hawkish tone from key policymakers as they reiterate the fight against inflation is not yet over. But it's also an opportunity for Fed Chair Jerome Powell to provide more guidance on the rate path going forward, given renewed data dependency and the perception of a policy pivot. It should be noted that past Jackson Hole events have sometimes delivered surprising statements from the Fed and other central banks," UBS added.

Back in London, Just Eat Takeaway.com jumped 39%. It has relinquished a 33% stake in the iFood joint-venture to Johannesburg- and Amsterdam-listed internet assets investor Prosus for up to EUR1.8 billion.

"Just Eat Takeaway.com remains focused on improving its profitability and on a disciplined allocation of capital. It will retain the transaction proceeds to maintain its balance sheet strength and to service repayments of its upcoming debt maturities," Just Eat said.

iFood has online food and delivery operations in Latin America. Prosus and its subsidiary Movile will fully own iFood after the deal is completed. Prosus was up 0.6% in Amsterdam.

The deal comes as Just Eat Takeaway explores a deal for its Grubhub unit. Just Eat completed its USD7.3 billion acquisition of Chicago, US-headquartered Grubhub in June last year. It first mulled a sale of Grubhub in April, and on Friday said it continues to "actively explore" this.

Kingspan shares surged 6.6%, after the building materials firm said it has "been able to navigate" input cost inflation.

For the six months that ended on June 30, revenue rose 42% to EUR4.15 billion from EUR2.92 billion a year earlier. It has the first time half-year revenue topped EUR4 billion.

Pretax profit surged 30% to EUR387.6 million from EUR297.2 million.

"Despite a challenging trading environment, Kingspan delivered record half year results, with revenues over EUR4 billion for the first time. We have been able to navigate large input cost increases with only modest margin impact," Chief Executive Gene Murtagh commented.

Kingspan upped its payout by 29% to 25.6 cents from 19.9 cents.

Helping to ensure the FTSE 100 outperformed continental peers, consumer goods firms Unilever and Reckitt rose 1.0% and 1.3%.

Pharmaceutical firms were also on the up, AstraZeneca was the best blue-chip performer, up 1.4%, while GSK added 0.9%. GSK shares have slid 2.4% this week, however, having slumped 13% the week before due to worries over possible Zantac litigation.

GSK on Tuesday said a first scheduled trial in its Zantac case was voluntarily dismissed. The pharma firm noted it did not pay anything in exchange for the voluntary dismissal.

The heartburn drug was withdrawn after the US Food & Drug Administration in 2019 warned that the product contained levels of NDMA, a probable human carcinogen - a substance which has been linked to cancer.

Travel stocks were grounded amid consumer confidence fears. British Airways parent International Consolidated Airlines Group fell 2.6%, budget carrier easyJet lost 4.3% and tour operator On the Beach shed 3.8%.

Brent oil was quoted at USD94.65 a barrel midday Friday, down from USD96.12 late Thursday. Gold was quoted at USD1,750.17 an ounce, down from USD1,761.70.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.